AbbVie Expected To Ditch Abicipar After US FDA Setback

 
• By Joseph Haas
  
Female eye with long eyelashes close up. Closeup shot of female gray - blue colour eye with day makeup. Beauty female eye with curl long eyelashes
FDA determined that abicipar's benefit don't outweigh its risk of intraocular inflammation
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip